MiMedx Total Stockholder Equity vs Common Stock Shares Outstanding Analysis

MDXG Stock  USD 9.59  0.04  0.42%   
MiMedx financial indicator trend analysis is infinitely more than just investigating MiMedx Group recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MiMedx Group is a good investment. Please check the relationship between MiMedx Total Stockholder Equity and its Common Stock Shares Outstanding accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Total Stockholder Equity vs Common Stock Shares Outstanding

Total Stockholder Equity vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MiMedx Group Total Stockholder Equity account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between MiMedx's Total Stockholder Equity and Common Stock Shares Outstanding is 0.45. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of MiMedx Group, assuming nothing else is changed. The correlation between historical values of MiMedx's Total Stockholder Equity and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of MiMedx Group are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Stockholder Equity i.e., MiMedx's Total Stockholder Equity and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.45
Relationship DirectionPositive 
Relationship StrengthWeak

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from MiMedx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MiMedx Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
At this time, MiMedx's Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The MiMedx's current Enterprise Value is estimated to increase to about 1 B, while Selling General Administrative is projected to decrease to roughly 123.2 M.
 2021 2023 2024 (projected)
Non Recurring53K47.7K45.3K
Reconciled Depreciation5.2M3.6M4.6M

MiMedx fundamental ratios Correlations

0.450.680.610.49-0.61-0.570.560.880.81-0.040.880.540.720.510.60.830.640.97-0.010.740.60.690.870.170.8
0.450.590.630.37-0.81-0.060.610.360.440.490.380.690.720.010.40.380.220.410.220.710.70.490.320.320.25
0.680.590.920.09-0.6-0.360.850.610.660.440.60.60.630.440.730.390.690.620.00.660.910.910.630.590.32
0.610.630.920.1-0.64-0.310.960.540.650.550.530.60.610.30.670.370.60.530.020.650.970.910.650.720.19
0.490.370.090.1-0.38-0.090.210.160.660.080.170.210.45-0.46-0.210.77-0.350.370.410.420.080.030.56-0.070.48
-0.61-0.81-0.6-0.64-0.380.51-0.58-0.68-0.45-0.29-0.69-0.62-0.64-0.15-0.35-0.62-0.35-0.61-0.05-0.68-0.67-0.49-0.52-0.28-0.31
-0.57-0.06-0.36-0.31-0.090.51-0.2-0.77-0.340.13-0.76-0.37-0.43-0.48-0.36-0.65-0.51-0.610.25-0.49-0.27-0.36-0.55-0.16-0.29
0.560.610.850.960.21-0.58-0.20.410.680.550.40.590.580.130.530.390.440.460.170.60.920.840.650.730.17
0.880.360.610.540.16-0.68-0.770.410.53-0.131.00.480.60.710.680.690.780.93-0.320.650.530.610.730.170.61
0.810.440.660.650.66-0.45-0.340.680.530.40.520.510.670.080.480.780.290.650.210.680.630.710.880.490.49
-0.040.490.440.550.08-0.290.130.55-0.130.4-0.130.320.25-0.320.320.0-0.08-0.210.060.240.580.430.20.84-0.48
0.880.380.60.530.17-0.69-0.760.41.00.52-0.130.490.610.70.670.70.770.93-0.310.660.520.590.720.150.62
0.540.690.60.60.21-0.62-0.370.590.480.510.320.490.880.270.50.480.430.490.40.860.60.570.350.370.3
0.720.720.630.610.45-0.64-0.430.580.60.670.250.610.880.260.560.690.430.660.230.990.580.620.570.30.49
0.510.010.440.3-0.46-0.15-0.480.130.710.08-0.320.70.270.260.730.070.940.63-0.420.30.330.50.23-0.010.44
0.60.40.730.67-0.21-0.35-0.360.530.680.480.320.670.50.560.730.230.850.59-0.440.590.690.790.520.550.24
0.830.380.390.370.77-0.62-0.650.390.690.780.00.70.480.690.070.230.190.760.120.710.330.380.840.130.61
0.640.220.690.6-0.35-0.35-0.510.440.780.29-0.080.770.430.430.940.850.190.71-0.350.470.610.740.420.240.44
0.970.410.620.530.37-0.61-0.610.460.930.65-0.210.930.490.660.630.590.760.71-0.10.680.530.610.770.020.84
-0.010.220.00.020.41-0.050.250.17-0.320.210.06-0.310.40.23-0.42-0.440.12-0.35-0.10.160.02-0.01-0.13-0.140.16
0.740.710.660.650.42-0.68-0.490.60.650.680.240.660.860.990.30.590.710.470.680.160.610.650.610.340.47
0.60.70.910.970.08-0.67-0.270.920.530.630.580.520.60.580.330.690.330.610.530.020.610.880.580.670.21
0.690.490.910.910.03-0.49-0.360.840.610.710.430.590.570.620.50.790.380.740.61-0.010.650.880.670.650.28
0.870.320.630.650.56-0.52-0.550.650.730.880.20.720.350.570.230.520.840.420.77-0.130.610.580.670.460.5
0.170.320.590.72-0.07-0.28-0.160.730.170.490.840.150.370.3-0.010.550.130.240.02-0.140.340.670.650.46-0.41
0.80.250.320.190.48-0.31-0.290.170.610.49-0.480.620.30.490.440.240.610.440.840.160.470.210.280.5-0.41
Click cells to compare fundamentals

MiMedx Account Relationship Matchups

MiMedx fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab56.7M50.4M35.0M35.1M37.0M22.9M
Common Stock Shares Outstanding105.6M108.3M110.4M112.9M146.0M94.7M
Other Liab621K3.8M4.9M2.3M2.1M2.6M
Net Tangible Assets6.6M91.4M(25.3M)(43.8M)(39.4M)(37.5M)
Other Assets443K375K186K148K133.2K126.5K
Property Plant Equipment15.7M11.4M13.9M11.3M12.9M10.9M

Currently Active Assets on Macroaxis

When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.1)
Earnings Share
0.57
Revenue Per Share
2.447
Quarterly Revenue Growth
0.029
Return On Assets
0.1838
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.